MASUI
CYTK icon

MIRAE ASSET SECURITIES (USA) INC.’s Cytokinetics CYTK Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,067
Closed -$1.91M – 179
2025
Q4 		$1.91M Buy
+30,067
New +$1.87M 0.05% 155

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s CYTK Position: Q1 2026 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Cytokinetics (CYTK) in Q1 2026, closing a stake of 30,067 shares — an estimated $1.91M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in CYTK in Q4 2025 and held it in 1 quarter. The position peaked at $1.91M in Q4 2025. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Cytokinetics position as of Q1 2026 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 30,067 Cytokinetics shares in Q1 2026, an estimated $1.91M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Cytokinetics in Q4 2025 and held it in 1 quarter.
  • MIRAE ASSET SECURITIES (USA) INC.'s Cytokinetics position peaked at $1.91M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q1 2026, filed 29 Apr 2026.